These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 24140079)

  • 1. Contribution of fetal ANXA5 gene promoter polymorphisms to the onset of pre-eclampsia.
    Ota S; Miyamura H; Nishizawa H; Inagaki H; Inagaki A; Inuzuka H; Suzuki M; Miyazaki J; Sekiya T; Udagawa Y; Kurahashi H
    Placenta; 2013 Dec; 34(12):1202-10. PubMed ID: 24140079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal carriers of the ANXA5 M2 haplotype are exposed to a greater risk for placenta-mediated pregnancy complications.
    Aranda F; Udry S; Perés Wingeyer S; Amshoff LC; Bogdanova N; Wieacker P; Latino JO; Markoff A; de Larrañaga G
    J Assist Reprod Genet; 2018 May; 35(5):921-928. PubMed ID: 29497952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Independent association of the M2/ANXA5 haplotype with recurrent pregnancy loss (RPL) in PCOS patients.
    Rogenhofer N; Engels L; Bogdanova N; Tüttelmann F; Thaler CJ; Markoff A
    Metabolism; 2013 Aug; 62(8):1057-60. PubMed ID: 23498654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Annexin A5 Promoter Haplotype M2 Is Not a Risk Factor for Recurrent Pregnancy Loss in Northern Europe.
    Nagirnaja L; Nõmmemees D; Rull K; Christiansen OB; Nielsen HS; Laan M
    PLoS One; 2015; 10(7):e0131606. PubMed ID: 26135579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haplotype M2 in the annexin A5 (ANXA5) gene and the occurrence of obstetric complications.
    Tiscia G; Colaizzo D; Chinni E; Pisanelli D; Sciannamè N; Favuzzi G; Margaglione M; Grandone E
    Thromb Haemost; 2009 Aug; 102(2):309-13. PubMed ID: 19652881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal and paternal carriage of the annexin A5 M2 haplotype: a possible risk factor for recurrent implantation failure (RIF).
    Rogenhofer N; Markoff A; Ennerst X; Bogdanova N; Thaler C
    J Assist Reprod Genet; 2021 Jan; 38(1):235-242. PubMed ID: 33231792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced allele specific annexin A5 mRNA levels in placentas carrying the M2/ANXA5 allele.
    Markoff A; Gerdes S; Feldner S; Bogdanova N; Gerke V; Grandone E
    Placenta; 2010 Oct; 31(10):937-40. PubMed ID: 20805002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced ANXA5 mRNA and protein expression in pregnancies complicated by preeclampsia.
    Gourvas V; Soulitzis N; Konstantinidou A; Dalpa E; Koukoura O; Koutroulakis D; Spandidos DA; Sifakis S
    Thromb Res; 2014 Mar; 133(3):495-500. PubMed ID: 24393658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression changes and clinical significance of annexin V in maternal blood and placenta in patients with preeclampsia].
    Xin H; Wang HL
    Zhonghua Fu Chan Ke Za Zhi; 2011 Feb; 46(2):88-93. PubMed ID: 21426764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological study of annexin A5 & apelin in pre-eclamptic placentae with emphasis on foetal outcome.
    Dasgupta S; Maity P; Banerjee U; Mukhopadhyay P; Saha S; Das B
    Indian J Med Res; 2021 Jun; 154(6):813-822. PubMed ID: 35662086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased annexin A5 mRNA placental expression in pregnancies complicated by fetal growth restriction.
    Sifakis S; Soufla G; Koukoura O; Soulitzis N; Koutroulakis D; Maiz N; Konstantinidou A; Melissari E; Spandidos DA
    Thromb Res; 2010 Apr; 125(4):326-31. PubMed ID: 20034656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The annexin A5 protective shield model revisited: inherited carriage of the M2/ANXA5 haplotype in placenta as a predisposing factor for the development of obstetric antiphospholipid antibodies.
    Bogdanova N; Baleva M; Kremensky I; Markoff A
    Lupus; 2012 Jun; 21(7):796-8. PubMed ID: 22635237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of nestin in normal and pre-eclamptic human placentas.
    Hwang HS; Cho NH; Maeng YS; Kang MH; Park YW; Kim YH
    Acta Obstet Gynecol Scand; 2007; 86(8):909-14. PubMed ID: 17653873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variations and haplotypes in the annexin A5 gene are associated with the risk of recurrent pregnancy loss.
    Lan Y; Wang J; Zhang Q; Yang X; Li L; Yin J; Li H; Song X; Chen Z; Liu Y
    J Cell Physiol; 2019 Aug; 234(10):18308-18316. PubMed ID: 30887514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Annexin V expression in human placenta is influenced by the carriership of the common haplotype M2.
    Chinni E; Tiscia GL; Colaizzo D; Vergura P; Margaglione M; Grandone E
    Fertil Steril; 2009 Mar; 91(3):940-2. PubMed ID: 18462735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of single nucleotide polymorphisms in the promoter region of the ANXA5 (annexin A5) gene with recurrent miscarriages in women of Greek origin.
    Dryllis G; Giannopoulos A; Zoi C; Pouliakis A; Logothetis E; Voulgarelis M; Zoi K; Kouskouni E; Dinou A; Stavropoulos-Giokas C; Kreatsas G; Konstantopoulos K; Politou M
    J Matern Fetal Neonatal Med; 2020 May; 33(9):1538-1543. PubMed ID: 30196743
    [No Abstract]   [Full Text] [Related]  

  • 17. Upregulation of HtrA4 in the placentas of patients with severe pre-eclampsia.
    Inagaki A; Nishizawa H; Ota S; Suzuki M; Inuzuka H; Miyamura H; Sekiya T; Kurahashi H; Udagawa Y
    Placenta; 2012 Nov; 33(11):919-26. PubMed ID: 22964307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicentre study of the clinical relevance of screening IVF patients for carrier status of the annexin A5 M2 haplotype.
    Fishel S; Patel R; Lytollis A; Robinson J; Smedley M; Smith P; Cameron C; Thornton S; Dowell K; Atkinson G; Shaker A; Lowe P; Kazem R; Brett S; Fox A
    Reprod Biomed Online; 2014 Jul; 29(1):80-7. PubMed ID: 24813755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A common haplotype of the annexin A5 (ANXA5) gene promoter is associated with recurrent pregnancy loss.
    Bogdanova N; Horst J; Chlystun M; Croucher PJ; Nebel A; Bohring A; Todorova A; Schreiber S; Gerke V; Krawczak M; Markoff A
    Hum Mol Genet; 2007 Mar; 16(5):573-8. PubMed ID: 17339269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of M2/ANXA5 haplotype as a risk factor in couples with placenta-mediated pregnancy complications.
    Rogenhofer N; Nienaber LRM; Amshoff LC; Bogdanova N; Petroff D; Wieacker P; Thaler CJ; Markoff A
    J Assist Reprod Genet; 2018 Jan; 35(1):157-163. PubMed ID: 28900802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.